Literature DB >> 23403166

Induction of apoptosis of leukemic cells by TRUE gene silencing using small guide RNAs targeting the WT1 mRNA.

Norihiro Watanabe1, Miwako Narita, Akie Yamahira, Tomoyo Taniguchi, Tatsuo Furukawa, Tetsuo Yoshida, Tatsuya Miyazawa, Masayuki Nashimoto, Masuhiro Takahashi.   

Abstract

TRUE gene silencing is a technology to eliminate specific cellular RNAs by using tRNase Z(L) and small guide RNA (sgRNA). Here we investigated how WT1-mRNA-targeting sgRNAs affect leukemic cells. We showed that sgRNA can be easily taken up by cells without any transfection reagents, and that the naked sgRNAs targeting the WT1 mRNA can reduce its mRNA levels and WT1 protein amounts in the WT1-expressing leukemic cells. Concomitantly, these sgRNAs efficiently induced apoptosis in these cells but not in WT1-nonexpressing cells. We also demonstrated that the reduction in the WT1 mRNA level is caused by its cleavage by tRNase Z(L).
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23403166     DOI: 10.1016/j.leukres.2013.01.015

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

Review 1.  TRUE Gene Silencing.

Authors:  Masayuki Nashimoto
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

2.  TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents.

Authors:  Arisa Haino; Tatsuya Ishikawa; Mineaki Seki; Masayuki Nashimoto
Journal:  J Vis Exp       Date:  2016-06-02       Impact factor: 1.355

3.  Growth inhibition of head and neck squamous cell carcinoma cells by sgRNA targeting the cyclin D1 mRNA based on TRUE gene silencing.

Authors:  Satoshi Iizuka; Nobuhiko Oridate; Masayuki Nashimoto; Satoshi Fukuda; Masato Tamura
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

4.  Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.

Authors:  Sho Ninomiya; Mitsuoki Kawano; Takashi Abe; Tatsuya Ishikawa; Masayuki Takahashi; Masato Tamura; Yoshiaki Takahashi; Masayuki Nashimoto
Journal:  PLoS One       Date:  2015-03-02       Impact factor: 3.240

5.  SIDT2 mediates gymnosis, the uptake of naked single-stranded oligonucleotides into living cells.

Authors:  Masayuki Takahashi; Viorica Raluca Contu; Chihana Kabuta; Katsunori Hase; Yuuki Fujiwara; Keiji Wada; Tomohiro Kabuta
Journal:  RNA Biol       Date:  2017-04-17       Impact factor: 4.652

6.  WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target.

Authors:  Bin Zhou; Xianghong Jin; Weiwei Jin; Xingzhou Huang; Yanfei Wu; Haiying Li; Weijian Zhu; Xiaoyi Qin; Haige Ye; Shenmeng Gao
Journal:  J Transl Med       Date:  2020-06-24       Impact factor: 5.531

7.  The heptamer sgRNA targeting the human OCT4 mRNA can upregulate the OCT4 expression.

Authors:  Tadasuke Nozaki; Masayuki Takahashi; Tatsuya Ishikawa; Arisa Haino; Mineaki Seki; Hidetomo Kikuchi; Bo Yuan; Masayuki Nashimoto
Journal:  Biochem Biophys Rep       Date:  2021-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.